Chymoral Forte is a proteolytic enzyme preparation that combines trypsin and chymotrypsin. Although it’s marketed as a non‑steroidal anti‑inflammatory drug (NSAID) for a wide range of musculoskeletal and post‑operative conditions, its anti‑inflammatory and anti‑edematous properties make it especially useful in oral surgery and periodontal therapy.
Why It’s Relevant to Dentistry
- Periodontal flap surgery – Reduces postoperative gingival swelling and discomfort, promoting faster tissue remodeling.
- Post‑extraction swelling – The enzymes help break down fibrin and inflammatory exudate, accelerating resolution of edema after tooth removal or surgical extractions.
- Maxillofacial trauma – Assists in managing soft‑tissue edema after facial fractures or osteotomies.
- Peri‑apical abscesses – May complement antibiotics by decreasing inflammatory fluid accumulation around the apex.
Typical Dosing (Adults)
| Indication | Recommended Dose | Frequency | Duration |
|---|---|---|---|
| Post-operative swelling (including dental extractions) | 1 tablet (usually 500 mg total of combined enzymes) | 2-3 times daily | 5-7 days, or until swelling subsides |
| Acute soft-tissue injury or sprain | 1 tablet | 2-3 times daily | 5-10 days |
Adjust dose for renal/hepatic impairment or elderly patients as needed.
Safety Highlights
- Boxed warning: None reported for Chymoral Forte.
- Key risks: Mild gastrointestinal upset (nausea, dyspepsia) and rare allergic reactions (rash, pruritus).
- Contraindications: Known hypersensitivity to trypsin, chymotrypsin, or any excipients; active peptic ulcer disease; severe hepatic impairment.
- Drug interactions: No major interactions, but avoid concurrent use with other NSAIDs to reduce cumulative GI irritation.
Practical Tips for Dental Clinicians
- Start early: Give the first dose immediately after surgery to blunt the inflammatory cascade.
- Combine with analgesics: Pair with acetaminophen or low‑dose ibuprofen for synergistic pain control without exceeding NSAID limits.
- Monitor for allergy: Observe the patient for any rash or swelling beyond the expected postoperative course.
- Educate patients: Explain that the medication works by “cleaning up” inflammatory proteins, not by acting like a traditional painkiller.
Quick Reference
- Indication: Post‑extraction, periodontal flap, maxillofacial surgery swelling.
- Dose: 1 tablet 2–3× daily for 5–7 days.
- Key safety: No boxed warning; watch for GI upset and allergic rash.
- When to avoid: Active peptic ulcer, severe liver disease, known enzyme allergy.
- Interaction check: Avoid stacking with additional NSAIDs.
Clinical Pearls
- Timing matters: Administer the first dose within the first hour post‑surgery for maximal edema control.
- Combine wisely: Pairing with acetaminophen provides analgesia while keeping NSAID load low.
- Allergy safety net: Keep an antihistamine on hand for patients with a history of drug‑induced urticaria.
- Patient compliance: The tablet size is small and can be taken with food to reduce stomach irritation.
- Documentation: Note the use of Chymoral Forte in the postoperative chart to track outcomes and any adverse events.
FAQ
It is a proteolytic enzyme blend (trypsin + chymotrypsin) that breaks down fibrin and inflammatory proteins, helping to reduce swelling and edema after oral surgery.
Ideal for post‑extraction swelling, periodontal flap surgery, and any maxillofacial procedure where soft‑tissue edema is expected.
One tablet (≈500 mg total enzymes) taken 2–3 times daily for 5–7 days, starting within the first hour after surgery.
No boxed warning. Watch for mild GI upset and rare allergic reactions. Contraindicated in patients with known enzyme allergy, active peptic ulcer disease, or severe hepatic impairment.
Yes—pair it with acetaminophen or low‑dose ibuprofen for synergistic pain control, but avoid stacking multiple NSAIDs to limit gastrointestinal irritation.